Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C C Chou

Showing results (181-190 of 217) with videos related to

Pageof 22
Sort By:
Journal of Veterinary Pharmacology and Therapeutics|September 16, 2010
Pharmacokinetics and tissue depletion of florfenicol in Leghorn and Taiwan Native chickensS K Chang, J L Davis, C N Cheng, et al.
Changgeng Yi Xue Za Zhi|March 1, 2000
Enterovesical fistula: experiences with 41 cases in 12 yearsC H Liu, C K Chuang, S H Chu, et al.
International Immunology|December 11, 1999
Mapping and characterization of the epitope(s) of Sch 55700, a humanized mAb, that inhibits human IL-5J Zhang, R Kuvelkar, N J Murgolo, et al.
The Journal of Biological Chemistry|May 26, 1995
Characterization of recombinant extracellular domain of human interleukin-10 receptorJ C Tan, S Braun, H Rong, et al.
Protein Expression and Purification|March 31, 1998
Expression, purification, and characterization of recombinant human interleukin-13 from NS-O cellsS Cannon-Carlson, J Varnerin, A Tsarbopoulos, et al.
Developmental Biology|January 1, 1987
mRNA species regulated during the differentiation of HL-60 cells to macrophages and neutrophilsR C Davis, A R Thomason, M L Fuller, et al.
Ma Zui Xue Za Zhi = Anaesthesiologica Sinica|June 1, 1985
[Clinical experience of continuous epidural anesthesia]J C Tung, M W Hsieh, C C Chou, et al.
Transplantation Proceedings|December 5, 1998
Converting renal transplant patients maintained on Sandimmune to a new microemulsion formulation, Sandimmune NeoralS H Chu, S T Pang, Y J Chiang, et al.
Cytokine|September 14, 2001
Human B cell-attracting chemokine 1 (BCA-1; CXCL13) is an agonist for the human CXCR3 receptorC H Jenh, M A Cox, W Hipkin, et al.
Chang Gung Medical Journal|January 12, 2005
The role of free to total prostate-specific antigen ratio for prostate cancer in screening patients with total serum levels between 4 and 20 ng/mlC T Wu, C K Chuang, C C Chou, et al.
Pageof 22

Showing results (181-190 of 217) with videos related to

Sort By:
Pageof 22
Journal of Veterinary Pharmacology and Therapeutics|September 16, 2010
Pharmacokinetics and tissue depletion of florfenicol in Leghorn and Taiwan Native chickensS K Chang, J L Davis, C N Cheng, et al.
Changgeng Yi Xue Za Zhi|March 1, 2000
Enterovesical fistula: experiences with 41 cases in 12 yearsC H Liu, C K Chuang, S H Chu, et al.
International Immunology|December 11, 1999
Mapping and characterization of the epitope(s) of Sch 55700, a humanized mAb, that inhibits human IL-5J Zhang, R Kuvelkar, N J Murgolo, et al.
The Journal of Biological Chemistry|May 26, 1995
Characterization of recombinant extracellular domain of human interleukin-10 receptorJ C Tan, S Braun, H Rong, et al.
Protein Expression and Purification|March 31, 1998
Expression, purification, and characterization of recombinant human interleukin-13 from NS-O cellsS Cannon-Carlson, J Varnerin, A Tsarbopoulos, et al.
Developmental Biology|January 1, 1987
mRNA species regulated during the differentiation of HL-60 cells to macrophages and neutrophilsR C Davis, A R Thomason, M L Fuller, et al.
Ma Zui Xue Za Zhi = Anaesthesiologica Sinica|June 1, 1985
[Clinical experience of continuous epidural anesthesia]J C Tung, M W Hsieh, C C Chou, et al.
Transplantation Proceedings|December 5, 1998
Converting renal transplant patients maintained on Sandimmune to a new microemulsion formulation, Sandimmune NeoralS H Chu, S T Pang, Y J Chiang, et al.
Cytokine|September 14, 2001
Human B cell-attracting chemokine 1 (BCA-1; CXCL13) is an agonist for the human CXCR3 receptorC H Jenh, M A Cox, W Hipkin, et al.
Chang Gung Medical Journal|January 12, 2005
The role of free to total prostate-specific antigen ratio for prostate cancer in screening patients with total serum levels between 4 and 20 ng/mlC T Wu, C K Chuang, C C Chou, et al.
Pageof 22